Activism & Advocacy

Pharma Industry’s Job is NOT Disease Prevention. THAT’S YOUR JOB.

I’ve heard the argument, so have you. “Those evil pharma companies aren’t interested in prevention! They want people to get sick and stay sick because that’s how they make their money! On the drugs!” Recently I had railed against the pharma companies that are capitalizing on increasing trends of people using certain prescription drugs as [...]

Read the full article →

Female Sexual Dysfunction: Pharma’s Next Lifestyle Market

I’m posting this from one of Steve Woodruff’s blog posts that I shared via my Facebook profile, which turned into a full blown debate between me, Dmitriy Kruglyak, and Yvette – one of my FB friends. Jane Chin I’m pro-pharma, but I’m NOT happy w/ female sexual dysfunction disease mongering I expect to see from [...]

Read the full article →

How to See Through Pharma Ad BS?

Like all marketing campaigns, the aim of any pharma advertisement is to get you to think that you need a certain product or a service. I understand that all pharma companies will say that they want to educate patients on the condition first and foremost, but I guarantee that when pharma companies are forking over [...]

Read the full article →

Will Healthcare Become a Moral Question? (Are we already there?)

By Jane Chin This morning I was skyping with one of my favorite people, Bhupesh of Ethnicomm, when we began talking about the current state of healthcare. Bhupesh lives in Canada, where healthcare is socialized in a way that has become apparently very attractive to various healthcare “activists” and interest groups here in the U.S. [...]

Read the full article →

Provenge and FDA’s Etiology For Not Approving

By Dan Abshear Terminal patients are those who are not expected to live due to usually illness such as advanced prostate cancer (cT3). If the patient has 6 months or less to live, those patients are considered terminally ill. Regardless, if a patient is terminal, they are without a cure or tolerable treatment for their [...]

Read the full article →

← Previous Entries

Next Entries →